Laparoscopic cytoreductive surgery and HIPEC is effective regarding peritoneum tissue paclitaxel distribution
In some patients with peritoneal carcinomatosis, we could perform the cytoreductive surgery and the HIPEC procedure by a complete laparoscopic approach to avoid morbidity. We consider that using laparoscopic approach for performing peritoneal carcinomatosis cytoreductive surgery and HIPEC with closed CO2 recirculation technique is possible and safe, with equal efficacy to conventional methods and hemodynamic complications.
Monitoring the effectiveness of the drug distribution in a laparoscopic ctoreductive and HIPEC surgery group with CO2 recirculation respect to a closed and open HIPEC group
Porcine model that included fifteen mini-pigs. Five pigs were operated with laparoscopic approach performing a pelvic and retroperitoneal lymphadenectomy. They later received a total laparoscopic closed HIPEC with CO2 recirculation (G1). Group 2 (G2): five pigs operated by an open cytoreductive surgery and closed HIPEC technique. Group 3 (G3): five animals in which an open cytoreductive surgery and an open HIPEC technique was performed. Blood and peritoneal determinations were realized after recirculation of the drug, at 60 min using chromatographic analysis.
G1–G2: phrenic right peritoneum, p: 0.46. Phrenic left peritoneum, p: 0.46. Pelvic peritoneum, p: 0.17. Serum paclitaxel: p: 0.01. G1–G3: phrenic right peritoneum, p: 0.34. Phrenic left peritoneum, p: 0.34. Pelvic peritoneum, p: 0.17. Serum paclitaxel G1–G3, p: 0.02.
A total laparoscopic approach for ctoreductive surgery and closed HIPEC with CO2 recirculation may be safe and feasible. In our experimental model there was no significant difference in tissue drug distribution respect the conventional techniques and there was a less toxicity because the serum drug concentration was significantly lower with laparoscopic approach respect the other groups.
KeywordsLaparoscopy HIPEC Paclitaxel Hyperthermic intra-abdominal chemotherapy Peritoneum paclitaxel distribution
Hyperthermic intraperitoneal chemotherapy
To Foundation “Eugenio Rodriguez Pascual” for its Grant that allowed us to perform this project
DP-V, JR, PV, JM, have made the conception,design of the study, and acquisition-analysis of data. JO, AE, TP, EF, SS, SeS, PF, VB, AA, OM, JF, PM, have made the acquisition-analysis of data. DP-V and JM have made the final approval of the version that will be submitted.
Compliance with ethical standards
Conflict of interest
The authors, David Padilla-Valverde, Pedro Villarejo, Javier Redondo, Julen Oyarzabal, Ander Estella, Teodoro Palomino, Esther Fernandez, Susana Sanchez, Sergio Sánchez, Patricia Faba MD, Victor Baladron, Ana Alberca, Javier Fernández, Omar Montenegro, Pilar Marta, Jesus Martín, report no conflicts of interest.
- 2.Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res. 1984;44:605–12.Google Scholar
- 12.Simon L, Halilou MC, Gladieff L, Gadiou M, Herin F, Hennebelle I, et al. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel. Bull Cancer. 2009;96:971–7.Google Scholar
- 14.Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863–9.CrossRefGoogle Scholar
- 15.Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006;106:1144–53.CrossRefGoogle Scholar
- 18.Eichhorn V, Goepfert MS, Eulenburg C, Malbrain ML, Reuter DA. Comparison of values in critically ill patients for global end-diastolic volume and extravascular lung water measured by transcardiopulmonary thermodilution: a meta-analysis of the literature. Med Intensiva. 2012;36:467–74.CrossRefGoogle Scholar
- 19.Huber W, Umgelter A, Reindl W, Franzen M, Schmidt C, von Delius S, et al. Volume assessment in patients with necrotizing pancreatitis: a comparison of intrathoracic blood volumen index, central venous pressure, and hematocrit, and their correlation to cardiac index and extravascular lung water. Crit Care Med. 2008;36:2348–54.CrossRefGoogle Scholar
- 22.Feltracco P, Biancofiore G, Ori C, Saner FH, Della Rocca G. Limits and pitfalls of haemodynamic monitoring systems in liver transplantation surgery. Minerva Anastesiol. 2012;78:1372–84.Google Scholar
- 25.Sloothaak DAM, Gardenbroek TJ, Crezee J, Bemelman WA, Punt CJ, Buskens CJ, et al. Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis. EJSO. 2014;40:1453–8.CrossRefGoogle Scholar
- 28.Sánchez García S, Padilla Valverde D, Villarejo Campos P, Martin-Fernandez J, Garcia-Rojo M, Rodriguez-Martinez M. Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat® CO2 recirculation system. Surgery. 2014;155(4):719–25.CrossRefGoogle Scholar
- 29.Sánchez García S, Villarejo Campos P, Padilla Valverde D, Amo-Salas M, Martin-Fernandez J. Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed-abdomen technique (Combat PRS-1.0): a clinical pilot study. Int J Hyperth. 2016;32(5):488–98.CrossRefGoogle Scholar
- 30.Padilla-Valverde D, Sanchez-Garcia S, García-Santos E, Marcote-Ibañez C, Molina-Robles M, Martin-fernandez J, et al. Usefulness of thermographic analysis to control temperature homogeneity in the development and implementation of a closed recirculating CO2 chemohyperthermia model. Int J Hyperth. 2016;30:1–7.Google Scholar
- 31.García-Santos EP, Padilla-Valverde D, Villarejo-Campos P, Murillo-Lazaro C, Fernandez-grande E, Palomino-Muñoz T, et al. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR10. Pancreatology. 2016;16(4):632–9.CrossRefGoogle Scholar
- 32.Pascual-Ramírez J, Sánchez-García S, González-Ruizdelaherrán F, Villarejo-Campos P, LopezdelaManzanara C, Haya-Palazuelo J, et al. Security and efficiency of a closed-system, turbulent-flow circuit for hyperthermic intraperitoneal chemotherapy after cytoreductive ovarian surgery: perioperative outputs. Arch Gynecol Obstet. 2014;290:121–9.CrossRefGoogle Scholar
- 33.Sanchez-García S, Padilla-Valverde D, Villarejo-Campos P, Garcia-santos E, Martin-Fernandez J. Hyperthermic chemotherapy intra-abdominal laparoscopic approach: development of a laparoscopic model using CO2 recirculation system and clinical translation in peritoneal carcinomatosis. Int J Hyperth. 2017;33:684–9.CrossRefGoogle Scholar
- 36.Piche N, Leblond FA, Sidéris L, Pichette V, Drolet P, Fotier LP, et al. Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis. A study of the effect of heat on intraperitoneal oxaliplatin using a murine model. Ann Surg. 2011;254:138–44.CrossRefGoogle Scholar